Human nonpolio enteroviruses

Molecular Detection of Human Viral Pathogens

Volumn , Issue , 2016, Pages 37-51

  Sofer, Danit ^a   Weil, Merav ^a   Hindiyeh, Musa ^a   Ram, Daniela ^a   Shulman, Lester M ^a   Mendelson, Ella ^a  

^a MINISTRY OF HEALTH   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85052320004     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (167)

1. Stanway, G., Family Picornaviridae, in Virus Taxonomy: Eighth Report of the International Committee on Taxonomy of Viruses, eds. C. M. Fauquet, et al. (Elsevier, London, 2005), 757.
2. Oberste, M. S. et al., Molecular evolution of the human enteroviruses: Correlation of serotype with VP1 sequence and application to picornavirus classification, J. Virol., 73, 1941, 1999.
3. Oberste, M. S., et al., Typing of human enteroviruses by partial sequencing of VP1, J. Clin. Microbiol., 37, 1288, 1999.
4. Oberste, M. S., et al., Molecular identification of 13 new enterovirus types, EV79-88, EV97, and EV100-101, members of the species Human Enterovirus B, Virus Res., 128, 34, 2007.
5. Norder, H., et al., Sequencing of "untypable" enteroviruses reveals two new types, EV-77 and EV-78, within human enterovirus type B and substitutions in the BC loop of the VP1 protein for known types, J. Gen. Virol., 84, 827, 2003.
6. Caro, V., et al., Molecular strategy for "serotyping" of human enteroviruses, J. Gen. Virol., 82, 79, 2001.
7. Ghazi, F., et al., Molecular analysis of human parechovirus type 2 (formerly echovirus 23), J. Gen. Virol., 79, 2641, 1998.
8. Harvala, H., and Simmonds, P., Human parechoviruses: Biology, epidemiology and clinical significance, J. Clin. Virol., 45, 1, 2009.
9. Filman, D. J., et al., Structure determination of echovirus 1, Acta Crystallogr. D Biol. Crystallogr., 54, 1261, 1998.
10. Hendry, E., et al., The crystal structure of coxsackievirus A9: New insights into the uncoating mechanisms of enteroviruses, Structure, 7, 1527, 1999.
11. Hogle, J. M., Chow, M., and Filman, D. J., Three-dimensional structure of poliovirus at 2.9 A resolution, Science, 229, 1358, 1985.
12. Hogle, J. M., and Filman, D. J., Poliovirus: Three-dimensional structure of a viral antigen, Adv Vet Sci Comp Med., 33, 65, 1989.
13. Muckelbauer, J. K., et al., The structure of coxsackievirus B3 at 3.5 A resolution, Structure, 3, 653, 1995.
14. Stuart, A. D., et al., Determination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection, J. Virol., 76, 7694, 2002.
15. Xiao, C., et al., The crystal structure of coxsackievirus A21 and its interaction with ICAM-1, Structure, 13, 1019, 2005.
16. Stanway, G., Structure, function and evolution of picornaviruses, J. Gen. Virol., 71, 2483, 1990.
17. Rossmann, M. G., He, Y., and Kuhn, R. J., Picornavirusreceptor interactions, Trends Microbiol., 10, 324, 2002.
18. Barnard, D. L., et al., In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: Novel capsidbinding inhibitors with potent antipicornavirus activity, Antimicrob Agents Chemother., 48, 1766, 2004.
19. Pevear, D. C., et al., Activity of pleconaril against enteroviruses, Antimicrob. Agents Chemother., 43, 2109, 1999.
20. Lindberg, A. M., Stalhandske, P. O., and Pettersson, U., Genome of coxsackievirus B3, Virology, 156, 50, 1987.
21. Kitamura, N., et al., Primary structure, gene organization and polypeptide expression of poliovirus RNA, Nature, 291, 547, 1981.
22. Pelletier, J., and Sonenberg, N., Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA, Nature, 334, 320, 1988.
23. Fernandez-Miragall, O., Lopez de Quinto, S., and Martinez-Salas, E., Relevance of RNA structure for the activity of picornavirus IRES elements, Virus Res., 139, 172, 2009.
24. Yogo, Y., and Wimmer, E., Polyadenylic acid at the 3'-terminus of poliovirus RNA, Proc. Natl. Acad. Sci. USA, 69, 1877, 1972.
25. Jacobson, S. J., Konings, D. A., and Sarnow, P., Biochemical and genetic evidence for a pseudoknot structure at the 3' terminus of the poliovirus RNA genome and its role in viral RNA amplification, J. Virol., 67, 2961, 1993.
26. Racaniello, V. R., Picornaviridae: The viruses and their replication, in Fields Virology, 5th ed., eds. D. M. Knipe and P. M. Howley (LW&W, Philadelphia, 2007), 795.
27. Sean, P., and Semler, B. L., Coxsackievirus B RNA replication: Lessons from poliovirus, Curr Top Microbiol. Immunol., 323, 89, 2008.
28. Bergelson, J. M., et al., The integrin VLA-2 binds echovirus 1 and extracellular matrix ligands by different mechanisms, J. Clin. Invest., 92, 232, 1993.
29. Heikkila, O., et al., Integrin (alpha)V(beta)6 is a high-affinity receptor for coxsackievirus A9, J. Gen. Virol., 90, 197, 2009.
30. Roivainen, M., et al., Entry of coxsackievirus A9 into host cells: Specific interactions with alpha v beta 3 integrin, the vitronectin receptor, Virology, 203, 357, 1994.
31. Bergelson, J. M., et al., Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses, Proc. Natl. Acad. Sci. USA, 91, 6245, 1994.
32. Shafren, D. R., et al., Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry, J. Virol., 71, 4736, 1997.
33. Spiller, O. B., et al., Echoviruses and coxsackie B viruses that use human decay-accelerating factor (DAF) as a receptor do not bind the rodent analogues of DAF, J. Infect. Dis., 181, 340, 2000.
34. Carson, S. D., Receptor for the group B coxsackieviruses and adenoviruses: CAR, Rev. Med. Virol., 11, 219, 2001.
35. Mendelsohn, C. L., Wimmer, E., and Racaniello, V. R., Cellular receptor for poliovirus: Molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily, Cell, 56, 855, 1989.
36. Ward, T., et al., Role for beta2-microglobulin in echovirus infection of rhabdomyosarcoma cells, J. Virol., 72, 5360, 1998.
37. Fricks, C. E., and Hogle, J. M., Cell-induced conformational change in poliovirus: Externalization of the amino terminus of VP1 is responsible for liposome binding, J. Virol., 64, 1934, 1990.
38. Hogle, J. M., Poliovirus cell entry: Common structural themes in viral cell entry pathways, Annu. Rev. Microbiol., 56, 677, 2002.
39. Chung, S. K., et al., Internalization and trafficking mechanisms of coxsackievirus B3 in HeLa cells, Virology, 333, 31, 2005.
40. Pietiainen, V. M., et al., Viral entry, lipid rafts and caveosomes, Ann. Med., 37, 394, 2005.
41. Plekhova, N. G., et al., The center of viruses family Picornaviridae in residents macrophages, Tsitologiia, 50, 171, 2008.
42. Ambros, V., Pettersson, R. F., and Baltimore, D., An enzymatic activity in uninfected cells that cleaves the linkage between poliovirion RNA and the 5' terminal protein, Cell, 15, 1439, 1978.
43. Lee, Y. F., et al., A protein covalently linked to poliovirus genome RNA, Proc. Natl. Acad. Sci. USA, 74, 59, 1977.
44. Bonderoff, J. M., and Lloyd, R. E., CVB translation: Lessons from the polioviruses, Curr. Top. Microbiol. Immunol., 323, 123, 2008.
45. Schmid, M., and Wimmer, E., IRES-controlled protein synthesis and genome replication of poliovirus, Arch. Virol. Suppl., 9, 279, 1994.
46. Bedard, K. M., and Semler, B. L., Regulation of picornavirus gene expression, Microbes Infect., 6, 702, 2004.
47. Bienz, K., et al., Structural organization of poliovirus RNA replication is mediated by viral proteins of the P2 genomic region, J. Virol., 64, 1156, 1990.
48. Paul, A. V., et al., Protein-primed RNA synthesis by purified poliovirus RNA polymerase, Nature, 393, 280, 1998.
49. Domingo, E., et al., Coxsackieviruses and quasispecies theory: Evolution of enteroviruses, Curr. Top. Microbiol. Immunol., 323, 3, 2008.
50. Etchison, D., et al., Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex, J. Biol. Chem., 257, 14806, 1982.
51. Lloyd, R. E., Translational control by viral proteinases, Virus Res., 119, 76, 2006.
52. Banerjee, R., et al., Modifications of both selectivity factor and upstream binding factor contribute to poliovirus-mediated inhibition of RNA polymerase I transcription, J. Gen. Virol., 86, 2315, 2005.
53. Kliewer, S., and Dasgupta, A., An RNA polymerase II transcription factor inactivated in poliovirus-infected cells copurifies with transcription factor TFIID, Mol. Cell. Biol., 8, 3175, 1988.
54. Gustin, K. E., and Sarnow, P., Effects of poliovirus infection on nucleo-cytoplasmic trafficking and nuclear pore complex composition, EMBO J., 20, 240, 2001.
55. Doedens, J. R., Giddings, T. H., Jr., and Kirkegaard, K., Inhibition of endoplasmic reticulum-to-Golgi traffic by poliovirus protein 3A: Genetic and ultrastructural analysis, J. Virol., 71, 9054, 1997.
56. Doedens, J. R., and Kirkegaard, K., Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A, EMBO J., 14, 894, 1995.
57. Lenk, R., and Penman, S., The cytoskeletal framework and poliovirus metabolism, Cell, 16, 289 301, 1979.
58. Grandien, M., Forsgren, M., and Ehrnst, A., Enteroviruses and reoviruses, in Diagnostic Procedures For Viral, Rickettsial and Chlamydial Infections, 6th ed., eds. N. J. Schmidt and R. W. Emmons (APHA, Washington, DC, 1989), 513.
59. Pallanch, R., Enteroviruses, polioviruses, coxsackieviruses, echoviruses and newer enteroviruses, in Fields Virology, 5th ed., eds. D. M. Knipe and P. M. Howley (LW&W, Philadelphia, PA, 2007), 839.
60. Grist, N. R., Bell, E. J., and Assaad, F., Enteroviruses in human disease, Prog. Med. Virol., 24, 114, 1978.
61. Romero, J. R., and Rotbart, H. A., Enteroviruses, in Manual of Clinical Microbiology, 8th ed., eds. P. R. Murray, et al. (American Society for Microbiology, Washington, DC, 2003), 1427.
62. Gear, J. H., Nonpolio causes of polio-like paralytic syndromes, Rev. Infect. Dis., 6, S379, 1984.
63. Kumar, R., Aseptic meningitis: Diagnosis and management, Indian J. Pediatr., 72, 57, 2005.
64. Outbreaks of aseptic meningitis associated with echoviruses 9 and 30 and preliminary surveillance reports on enterovirus activity-United States, 2003, MMWR, 52, 761, 2003.
65. Rotbart, H. A., Enteroviral infections of the central nervous system, Clin. Infect. Dis., 20, 971, 1995.
66. Lee, B. E., and Davies, H. D., Aseptic meningitis, Curr. Opin. Infect. Dis., 20, 272, 2007.
67. Lewis, P., and Glaser, C. A., Encephalitis, Pediatr. Rev., 26, 353, 2005.
68. Stambos, V., Brussen, K. A., and Thorley, B. R., Annual report of the Australian National Poliovirus Reference Laboratory, 2004, Commun. Dis. Intell., 29, 263, 2005.
69. Kapoor, A., Ayyagari, A., and Dhole, T. N., Non-polio enteroviruses in acute flaccid paralysis, Indian J. Pediatr., 68, 927, 2001.
70. Kelly, H., et al., Polioviruses and other enteroviruses isolated from faecal samples of patients with acute flaccid paralysis in Australia, 1996-2004, J. Paediatr. Child Health, 42, 370, 2006.
71. Ooi, M. H., et al., Adenovirus type 21-associated acute flaccid paralysis during an outbreak of hand-foot-and-mouth disease in Sarawak, Malaysia, Clin. Infect. Dis., 36, 550, 2003.
72. Solomon, T., and Willison, H., Infectious causes of acute flaccid paralysis, Curr. Opin. Infect. Dis., 16, 375, 2003.
73. Tam, C. C., O'Brien, S. J., and Rodrigues, L. C., Influenza, campylobacter and mycoplasma infections, and hospital admissions for Guillain-Barre syndrome, England, Emerg. Infect. Dis., 12, 1880, 2006.
74. Chen, C. Y., et al., Acute flaccid paralysis in infants and young children with enterovirus 71 infection: MR imaging findings and clinical correlates, Am J Neuroradiol., 22, 200, 2001.
75. Perez-Velez, C. M., et al., Outbreak of neurologic enterovirus type 71 disease: A diagnostic challenge, Clin. Infect. Dis., 45, 950, 2007.
76. Grist, N. R., and Bell, E. J., Paralytic poliomyelitis and nonpolio enteroviruses: Studies in Scotland, Rev. Infect. Dis., 6, S385, 1984.
77. Chung, J. Y., et al., Respiratory picornavirus infections in Korean children with lower respiratory tract infections, Scand. J. Infect. Dis., 39, 250, 2007.
78. Abzug, M. J., et al., Viral pneumonia in the first month of life, Pediatr. Infect. Dis. J., 9, 881, 1990.
79. Jartti, T., et al., Respiratory picornaviruses and respiratory syncytial virus as causative agents of acute expiratory wheezing in children, Emerg. Infect. Dis., 10, 1095, 2004.
80. Jacques, J., et al., Epidemiological, molecular, and clinical features of enterovirus respiratory infections in French children between 1999 and 2005, J. Clin. Microbiol., 46, 206, 2008.
81. Frydenberg, A., and Starr, M., Hand, foot and mouth disease, Aust. Fam. Physician, 32, 594, 2003.
82. Bendig, J. W., O'Brien, P. S., and Muir, P., Serotype-specific detection of coxsackievirus A16 in clinical specimens by reverse transcription-nested PCR, J. Clin. Microbiol., 39, 3690, 2001.
83. McMinn, P. C., An overview of the evolution of enterovirus 71 and its clinical and public health significance, FEMS Microbiol. Rev., 26, 91, 2002.
84. Ang, L. W., et al., Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007, Ann. Acad. Med. Singapore, 38, 106, 2009.
85. Kono, R., Apollo 11 disease or acute hemorrhagic conjunctivitis: A pandemic of a new enterovirus infection of the eyes, Am. J. Epidemiol., 101, 383, 1975.
86. Kuo, P. C., et al., Molecular and immunocytochemical identification of coxsackievirus A-24 variant from the acute haemorrhagic conjunctivitis outbreak in Taiwan in 2007, Eye, 2009.
87. Shulman, L. M., et al., Identification of a new strain of fastidious enterovirus 70 as the causative agent of an outbreak of hemorrhagic conjunctivitis, J. Clin. Microbiol., 35, 2145, 1997.
88. Mahrholdt, H., et al., Presentation, patterns of myocardial damage, and clinical course of viral myocarditis, Circulation, 114, 1581, 2006.
89. Kawai, C., From myocarditis to cardiomyopathy: Mechanisms of inflammation and cell death: Learning from the past for the future, Circulation, 99, 1091, 1999.
90. Bowles, N. E., et al., Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy, Lancet, 1, 1120, 1986.
91. Jin, O., et al., Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction, Circulation, 82, 8, 1990.
92. Schwaiger, A., et al., Detection of enteroviral ribonucleic acid in myocardial biopsies from patients with idiopathic dilated cardiomyopathy by polymerase chain reaction, Am. Heart J., 126, 406, 1993.
93. Mavrouli, M. D., et al., Serologic prevalence of coxsackievirus group B in Greece, Viral Immunol., 20, 11, 2007.
94. Dunn, J. J., et al., The stem loop II within the 5' nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model, J. Infect. Dis., 187, 1552, 2003.
95. Abzug, M. J., Presentation, diagnosis, and management of enterovirus infections in neonates, Paediatr. Drugs, 6, 1, 2004.
96. Jenista, J. A., Powell, K. R., and Menegus, M. A., Epidemiology of neonatal enterovirus infection, J. Pediatr., 104, 685, 1984.
97. Shattuck, K. E., and Chonmaitree, T., The changing spectrum of neonatal meningitis over a fifteen-year period, Clin. Pediatr. (Phila), 31, 130, 1992.
98. Nathan, M., et al., Enteroviral sepsis and ischemic cardiomyopathy in a neonate: Case report and review of literature, Asaio J., 54, 554, 2008.
99. Modlin, J. F., Echovirus infections of newborn infants, Pediatr. Infect. Dis. J., 7, 311, 1988.
100. Ornoy, A., and Tenenbaum, A., Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses, Reprod. Toxicol., 21, 446, 2006.
101. Atkinson, M. A., and Eisenbarth, G. S., Type 1 diabetes: New perspectives on disease pathogenesis and treatment, Lancet, 358, 221, 2001.
102. Davies, J. L., et al., A genome-wide search for human type 1 diabetes susceptibility genes, Nature, 371, 130, 1994.
103. Sherry, N. A., Tsai, E. B., and Herold, K. C., Natural history of beta-cell function in type 1 diabetes, Diabetes, 54, S32, 2005.
104. Vyse, T. J., and Todd, J. A., Genetic analysis of autoimmune disease, Cell, 85, 311, 1996.
105. Akerblom, H. K., et al., Environmental factors in the etiology of type 1 diabetes, Am. J. Med. Genet., 115, 18, 2002.
106. Jaeckel, E., Manns, M., and Von Herrath, M., Viruses and diabetes, Ann. N. Y. Acad. Sci., 958, 7, 2002.
107. Lonnrot, M., et al., Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: The Finnish Diabetes Prediction and Prevention Study, Diabetes, 49, 1314, 2000.
108. Hyoty, H., Enterovirus infections and type 1 diabetes, Ann. Med., 34, 138, 2002.
109. Dahlquist, G. G., et al., Increased prevalence of enteroviral RNA in blood spots from newborn children who later developed type 1 diabetes: A population-based case-control study, Diabetes Care, 27, 285, 2004.
110. Helfand, R. F., et al., Serologic evidence of an association between enteroviruses and the onset of type 1 diabetes mellitus. Pittsburgh Diabetes Research Group, J. Infect. Dis., 172, 1206, 1995.
111. Roivainen, M., et al., Several different enterovirus serotypes can be associated with prediabetic autoimmune episodes and onset of overt IDDM. Childhood Diabetes in Finland (DiMe) Study Group, J. Med. Virol., 56, 74, 1998.
112. Elfving, M., et al., Maternal enterovirus infection during pregnancy as a risk factor in offspring diagnosed with type 1 diabetes between 15 and 30 years of age, Exp. Diabetes Res., 2008, 271958, 2008.
113. Viskari, H., et al., Relationship between the incidence of type 1 diabetes and maternal enterovirus antibodies: Time trends and geographical variation, Diabetologia, 48, 1280, 2005.
114. Viskari, H. R., et al., Maternal first-trimester enterovirus infection and future risk of type 1 diabetes in the exposed fetus, Diabetes, 51, 2568, 2002.
115. Skarsvik, S., et al., Decreased in vitro type 1 immune response against coxsackie virus B4 in children with type 1 diabetes, Diabetes, 55, 996, 2006.
116. Stalkup, J. R., and Chilukuri, S., Enterovirus infections: A review of clinical presentation, diagnosis, and treatment, Dermatol. Clin., 20, 217, 2002.
117. Sawyer, M. H., Enterovirus infections: Diagnosis and treatment, Pediatr. Infect. Dis. J., 18, 1033, 1999.
118. Dagan, R., Nonpolio enteroviruses and the febrile young infant: Epidemiologic, clinical and diagnostic aspects, Pediatr. Infect. Dis. J., 15, 67, 1996.
119. Gondo, K., et al., Echovirus type 9 epidemic in Kagoshima, southern Japan: Seroepidemiology and clinical observation of aseptic meningitis, Pediatr. Infect. Dis. J., 14, 787, 1995.
120. Khetsuriani, N., et al., Enterovirus surveillance-United States, 1970-2005, MMWR Surveill. Summ., 55, 1, 2006.
121. Kmetzsch, C. I., et al., Echovirus 13 aseptic meningitis, Brazil, Emerg. Infect. Dis., 12, 1289, 2006.
122. Avellon, A., et al., Molecular analysis of echovirus 13 isolates and aseptic meningitis, Spain, Emerg. Infect. Dis., 9, 934, 2003.
123. Kirschke, D. L., et al., Outbreak of aseptic meningitis associated with echovirus 13, Pediatr. Infect. Dis. J., 21, 1034, 2002.
124. Somekh, E., et al., An outbreak of echovirus 13 meningitis in central Israel, Epidemiol. Infect., 130, 257, 2003.
125. Mullins, J. A., et al., Emergence of echovirus type 13 as a prominent enterovirus, Clin. Infect. Dis., 38, 70, 2004.
126. Melnick, J. L., Enterovirus type 71 infections: A varied clinical pattern sometimes mimicking paralytic poliomyelitis, Rev. Infect. Dis., 6, S387, 1984.
127. Chan, L. G., et al., Deaths of children during an outbreak of hand, foot, and mouth disease in Sarawak, Malaysia: Clinical and pathological characteristics of the disease. For the Outbreak Study Group, Clin. Infect. Dis., 31, 678, 2000.
128. Huang, C. C., et al., Neurologic complications in children with enterovirus 71 infection, N. Engl. J. Med., 341, 936, 1999.
129. Podin, Y., et al., Sentinel surveillance for human enterovirus 71 in Sarawak, Malaysia: Lessons from the first 7 years, BMC Public Health, 6, 180, 2006.
130. Bendig, J. W., and Fleming, D. M., Epidemiological, virological, and clinical features of an epidemic of hand, foot, and mouth disease in England and Wales, Commun. Dis. Rep. Rev., 6, R81, 1996.
131. Qiu, J., Viral outbreak in China tests government efforts, Nature, 458, 554, 2009.
132. Zhang, Y., et al., An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China, J. Clin. Virol., 44, 262, 2009.
133. Chinese Centre for Disease Control and Prevention and Office of the World Health Organization in China. Report on the hand, foot and mouth disease outbreak in Fuyang City, Anhui Province and prevention and control in China, May 2008 [accessed 5 June 2008]. Available at: http://www.wpro. who.int/NR/rdonlyres/591D6A7B-FB15-4E94-A1E9-1-D3381847D60/0/HFMDCCDC20080515ENG.pdf.
134. Archimbaud, C., et al., Impact of rapid enterovirus molecular diagnosis on the management of infants, children, and adults with aseptic meningitis, J. Med. Virol., 81, 42, 2009.
135. Melnick, J. L., et al., Lyophilized combination pools of enterovirus equine antisera: Preparation and test procedures for the identification of field strains of 42 enteroviruses, Bull. WHO, 48, 263, 1973.
136. Melnick, J. L., et al., Lyophilized combination pools of enterovirus equine antisera: Preparation and test procedures for the identification of field strains of 19 group A coxsackievirus serotypes, Intervirology, 8, 172, 1977.
137. Lin, T. L., et al., Rapid and highly sensitive coxsackievirus a indirect immunofluorescence assay typing kit for enterovirus serotyping, J. Clin. Microbiol., 46, 785, 2008.
138. Dundas, N., et al., Comparison of automated nucleic acid extraction methods with manual extraction, J. Mol. Diagn., 10, 311, 2008.
139. Knepp, J. H., et al., Comparison of automated and manual nucleic acid extraction methods for detection of enterovirus RNA, J. Clin. Microbiol., 41, 3532, 2003.
140. Chapman, N. M., et al., Molecular detection and identification of enteroviruses using enzymatic amplification and nucleic acid hybridization, J. Clin. Microbiol., 28, 843, 1990.
141. Rotbart, H. A., Diagnosis of enteroviral meningitis with the polymerase chain reaction, J. Pediatr., 117, 85, 1990.
142. Hymas, W. C., et al., Description and validation of a novel real-time RT-PCR enterovirus assay, Clin. Chem., 54, 406, 2008.
143. Taggart, E. W., et al., Use of heat labile UNG in an RT-PCR assay for enterovirus detection, J. Virol. Methods., 105, 57, 2002.
144. Young, P. P., Buller, R. S., and Storch, G. A., Evaluation of a commercial DNA enzyme immunoassay for detection of enterovirus reverse transcription-PCR products amplified from cerebrospinal fluid specimens, J. Clin. Microbiol., 38, 4260, 2000.
145. Dierssen, U., et al., Rapid routine detection of enterovirus RNA in cerebrospinal fluid by a one-step real-time RT-PCR assay, J. Clin. Virol., 42, 58, 2008.
146. Tapparel, C., et al., New molecular detection tools adapted to emerging rhinoviruses and enteroviruses, J. Clin. Microbiol., 47, 1742, 2009.
147. Verstrepen, W. A., Bruynseels, P., and Mertens, A. H., Evaluation of a rapid real-time RT-PCR assay for detection of enterovirus RNA in cerebrospinal fluid specimens, J. Clin. Virol., 25, S39, 2002.
148. Kares, S., et al., Real-time PCR for rapid diagnosis of enteroand rhinovirus infections using LightCycler, J. Clin. Virol., 29, 99, 2004.
149. Capaul, S. E., and Gorgievski-Hrisoho, M., Detection of enterovirus RNA in cerebrospinal fluid (CSF) using NucliSens EasyQ Enterovirus assay, J. Clin. Virol., 32, 236, 2005.
150. Chen, T. C., et al., Combining multiplex reverse transcription-PCR and a diagnostic microarray to detect and differentiate enterovirus 71 and coxsackievirus A16, J. Clin. Microbiol., 44, 2212, 2006.
151. Liu, Q., et al., Microarray-in-a-tube for detection of multiple viruses, Clin. Chem., 53, 188, 2007.
152. Cherkasova, E., et al., Microarray analysis of evolution of RNA viruses: Evidence of circulation of virulent highly divergent vaccine-derived polioviruses, Proc. Natl. Acad. Sci. USA, 100, 9398, 2003.
153. Iturriza-Gomara, M., Megson, B., and Gray, J., Molecular detection and characterization of human enteroviruses directly from clinical samples using RT-PCR and DNA sequencing, J. Med. Virol., 78, 243, 2006.
154. Silva, P. A., et al., Identification of enterovirus serotypes by pyrosequencing using multiple sequencing primers, J. Virol. Methods., 148, 260, 2008.
155. Casas, I., et al., Molecular characterization of human enteroviruses in clinical samples: Comparison between VP2, VP1, and RNA polymerase regions using RT nested PCR assays and direct sequencing of products, J. Med. Virol., 65, 138, 2001.
156. Ishiko, H., et al., Molecular diagnosis of human enteroviruses by phylogeny-based classification by use of the VP4 sequence, J. Infect. Dis., 185, 744, 2002.
157. Nasri, D., et al., Typing of human enterovirus by partial sequencing of VP2, J. Clin. Microbiol., 45, 2370, 2007.
158. Oberste, M. S., Maher, K., and Pallansch, M. A., Molecular phylogeny of all human enterovirus serotypes based on comparison of sequences at the 5' end of the region encoding VP2, Virus Res., 58, 35, 1998.
159. Kew, O. M., et al., Molecular epidemiology of polioviruses, Semin. Virol., 6, 401, 1995.
160. Norder, H., Bjerregaard, L., and Magnius, L. O., Homotypic echoviruses share aminoterminal VP1 sequence homology applicable for typing, J. Med. Virol., 63, 35, 2001.
161. Reimann, B. Y., Zell, R., and Kandolf, R., Mapping of a neutralizing antigenic site of Coxsackievirus B4 by construction of an antigen chimera, J. Virol., 65, 3475, 1991.
162. Oberste, M. S., Maher, K., and Pallansch, M. A., Molecular phylogeny and proposed classification of the simian picornaviruses, J. Virol., 76, 1244, 2002.
163. Thompson, J. D., et al., The CLUSTAL_X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools, Nucleic Acids Res., 25, 4876, 1997.
164. Lole, K. S., et al., Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination, J. Virol., 73, 152, 1999.
165. Domingo, E., et al., The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: Biological relevance-A review, Gene, 40, 1, 1985.
166. Eigen, M., Viral quasispecies, Sci. Am., 269, 42, 1993.
167. Dreier, J., Stormer, M., and Kleesiek, K., Use of bacteriophage MS2 as an internal control in viral reverse transcription-PCR assays, J. Clin. Microbiol., 43, 4551, 2005.